[PDF][PDF] Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT

M Ichise, JR Ballinger, H Golan, D Vines… - Journal of Nuclear …, 1996 - Soc Nuclear Med
Conclusion: Rv is preferredbecause it providesa theoreticallyvalid estimate of kg/k4,
independently of rCBF or CR. Alternatively, RAmight be preferred to RPEbecause the former …

[PDF][PDF] Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I] epidepride SPECT

M Ichise, M Fujita, JP Seibyl… - Journal of Nuclear …, 1999 - Soc Nuclear Med
Methods: Multilinear regression analysis (MLRA) and graphical analysis (GA) using plasma
parent (P) plus metabolite (M) activities as input and time activities of receptor-free (RF …

Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride

J Hirvonen, S Aalto, V Lumme, K Någren… - Nuclear medicine …, 2003 - journals.lww.com
Abstract 11 C-Raclopride is a widely used positron emission tomography (PET) tracer for
measurement of striatal D 2 dopamine receptor binding characteristics. Recently, 11 C …

[PDF][PDF] In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans

HF Kung, A Alavi, W Chang, MP Kung… - Journal of Nuclear …, 1990 - Soc Nuclear Med
Subjectschosen for initial studies were male volunteers (a total of nine, age: 18— 50,
mean= 28) who had no history of prior neurologic or psychiatric disorders. Informed consent …

[PDF][PDF] Simplified quantification and reproducibility studies of dopamine D2-receptor binding with iodine-123-IBF SPECT in healthy subjects

M Ichise, JR Ballinger, D Vines, S Tsai… - Journal of Nuclear …, 1997 - Soc Nuclear Med
ÖPECT imaging of dopamine D2-receptors using I23l-labeled benzamide analogs such as
[I23l] iodobenzamide (IBZM) and [I23l] iodobenzofuran (IBF) is a potentially useful tool to …

[PDF][PDF] Dynamic SPECT imaging of dopamine D2 receptors in human subjects with iodine-123-IBZM

JP Seibyl, SW Woods, SS Zoghbi… - Journal of Nuclear …, 1992 - Soc Nuclear Med
West Haven, Connecticut and the Division ofNuclear Medicine, University ofPennsylvania
School ofMedicine, Philadelphia, Pennsylvania these conditions. The plasma was …

[PDF][PDF] Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability

NPLG Verhoeff, O Kapucu… - Journal of Nuclear …, 1993 - Soc Nuclear Med
I f 1 slice). The thirdexperimentwas performedwith striatum-to-back ground and cerebellum-
to-background 1@ Iconcentration ratios varying from 1.2-10.8. The purpose was to …

Dopamine D2 receptor radiotracers [11C](+)-PHNO and [3H] raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo

PN McCormick, S Kapur, P Seeman… - Nuclear medicine and …, 2008 - Elsevier
INTRODUCTION: In vitro, the dopamine D2 receptor exists in two states, with high and low
affinity for agonists. The high-affinity state is the physiologically active state thought to be …

Noninvasive nuclear imaging enables the in vivo quantification of striatal dopamine receptor expression and raclopride affinity in mice

K Fischer, V Sossi, A Schmid… - Journal of Nuclear …, 2011 - Soc Nuclear Med
The increasing use of genetically engineered mice as animal models of human disease in
biomedical research, latest advances in imaging technologies, and development of novel …

[PDF][PDF] SPECT imaging of striatal dopamine release after amphetamine challenge

M Laruelle, A Abi-Dargham, CH van Dyck… - Journal of Nuclear …, 1995 - Soc Nuclear Med
In this study, we applied a tracer programmedinfusion technique (20, 21) with the SPECT D2
receptor probe [†œ-@ I] IBZM (22) to establish a stable baseline for evaluation of the d …